Researchers have developed a same-day, noninvasive positron emission tomography (PET)-based imaging approach to assess PD-L1…
Browsing: Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is a professional organization dedicated to promoting the science, technology, and practical application of nuclear medicine and molecular imaging. Established in 1954 and based in the United States, SNMMI serves a diverse membership that includes physicians, technologists, scientists, and pharmacists who specialize in the use of radioactive substances for diagnosis and therapy. The society provides education, conducts research, and advocates for the advancement of nuclear medicine and molecular imaging to improve patient care. SNMMI offers various resources such as scientific journals, guidelines, and continuing education programs to support its members’ professional development. Additionally, the society organizes annual meetings and conferences, fostering collaboration and innovation within the field. By advancing research and clinical practice, SNMMI aims to enhance the role of molecular imaging in the early detection, diagnosis, and treatment of diseases, including cancer, cardiovascular diseases, and neurological disorders.